Illumina stock gains 2.74 percent as Guggenheim lifts target

Published on 10/04/2026 at 09:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Illumina stock stood at USD 273.04 on October 2, 2026, while Guggenheim lifted its target to USD 305 from USD 226. Second-quarter revenue rose 9.5 percent.

CGI-Architekturrender eines modernen Biotech-Hauptgebäudes mit Glasfassade und Wasserbecken — Illumina Inc. Hauptgebäude US4523271090 als fotorealistisches Architektur-Render mit Glasfassade, Spiegelbecken und goldenem Abendlicht, Illustration mit AI erstellt.

Illumina Inc. stock (ISIN US4523271090) closed at USD 273.04 on Nasdaq on October 2, 2026, up 2.74 percent, leaving the shares 2.54 percent below their 52-week high of USD 280.17. The latest catalyst was a Guggenheim target increase from USD 226 to USD 305, reported by Markets Insider on October 1, 2026.

Guggenheim lifts target to USD 305

Guggenheim kept a Buy rating while raising its target by USD 79. At USD 273.04, the new target lies 11.7 percent above the October 2 closing price, a narrower gap than the headline target change alone suggests.

The broader view is less aggressive. MarketBeat reported on October 3, 2026, that Wall Street Zen cut Illumina from Buy to Hold and cited a consensus price target of USD 214.69. That consensus figure sits USD 58.35 below the latest Nasdaq close.

Q2 revenue rises 9.5 percent

Illumina generated USD 1.16 billion in second-quarter 2026 revenue, up 9.5 percent from the same quarter a year earlier. The earnings call transcript published by The Globe and Mail on July 30, 2026, also recorded non-GAAP EPS of USD 1.31, up 10 percent year over year.

The operating story is concentrated in clinical demand and the NovaSeq X platform. Management reported more than 95 NovaSeq X placements in Q2 2026, while sequencing instrument revenue reached USD 125 million, up 31 percent year over year, according to the same transcript.

Next results set for October 29

MarketBeat lists October 29, 2026, as Illumina's next earnings date. The checkpoint will test whether the Q2 growth profile and the raised full-year non-GAAP EPS guidance of USD 5.30 to USD 5.40 can support a share price already close to its yearly high.

Illumina stock stays near yearly high

Illumina stock had a market capitalization of USD 41.2 billion and a trading volume of 2,618,634 shares on October 2, 2026. Its Nasdaq price was USD 273.04, compared with a 52-week range of USD 88.00 to USD 280.17.